Bert Cruys

3.6k total citations
10 papers, 533 citations indexed

About

Bert Cruys is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Bert Cruys has authored 10 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Bert Cruys's work include Cancer Genomics and Diagnostics (5 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Bert Cruys is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Bert Cruys collaborates with scholars based in Belgium, United States and United Kingdom. Bert Cruys's co-authors include Peter Carmeliet, Guy Eelen, Katie Bentley, Stefan Vinckier, Saar Vandekeere, Mieke Dewerchin, Ulrike Brüning, Laura Bierhansl, Stephen Rayport and Luc Schoonjans and has published in prestigious journals such as Nature Communications, The EMBO Journal and Development.

In The Last Decade

Bert Cruys

10 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bert Cruys Belgium	8	324	230	62	59	58	10	533
Saar Vandekeere Belgium	3	282 0.9×	204 0.9×	44 0.7×	68 1.2×	37 0.6×	4	465
Shufang Zhao China	12	352 1.1×	127 0.6×	40 0.6×	51 0.9×	70 1.2×	23	634
Kateřina Rohlenová Czechia	9	383 1.2×	236 1.0×	34 0.5×	94 1.6×	65 1.1×	18	618
Kumi Takasawa Japan	14	269 0.8×	121 0.5×	94 1.5×	64 1.1×	125 2.2×	37	570
Paula P. Coelho Canada	7	336 1.0×	174 0.8×	53 0.9×	45 0.8×	50 0.9×	9	457
Bahram Khadivi United States	4	247 0.8×	315 1.4×	37 0.6×	62 1.1×	93 1.6×	5	484
Ruben Martherus Belgium	10	496 1.5×	400 1.7×	44 0.7×	32 0.5×	91 1.6×	14	741
Ganeshkumar Rajendran United States	12	445 1.4×	227 1.0×	33 0.5×	46 0.8×	91 1.6×	21	689
Noga Gadir United States	10	696 2.1×	186 0.8×	88 1.4×	86 1.5×	99 1.7×	18	871
Klaudia Polak United States	5	362 1.1×	230 1.0×	19 0.3×	110 1.9×	64 1.1×	6	560

Countries citing papers authored by Bert Cruys

Since Specialization

Citations

This map shows the geographic impact of Bert Cruys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Cruys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Cruys more than expected).

Fields of papers citing papers by Bert Cruys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Cruys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Cruys. The network helps show where Bert Cruys may publish in the future.

Co-authorship network of co-authors of Bert Cruys

This figure shows the co-authorship network connecting the top 25 collaborators of Bert Cruys. A scholar is included among the top collaborators of Bert Cruys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert Cruys. Bert Cruys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Cuppens, Kristof, Paul Baas, Bert Cruys, et al.. (2022). HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors. Lung Cancer. 170. 1–10. 16 indexed citations

Froyen, Guy, et al.. (2022). Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid Tumors. Cancers. 14(10). 2457–2457. 14 indexed citations

Cuppens, Kristof, Guy Froyen, Bert Cruys, et al.. (2020). 1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer. Annals of Oncology. 31. S713–S714. 1 indexed citations

Cuppens, Kristof, et al.. (2019). P2.04-76 Tumor Mutational Burden by TSO500 Next Generation Sequencing Panel and Clinical Outcome in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S738–S739. 1 indexed citations

Laviña, Bàrbara, Marco Castro, Colin Niaudet, et al.. (2018). Defective endothelial cell migration in the absence of Cdc42 leads to capillary-venous malformations. Development. 145(13). 55 indexed citations

Huang, Hongling, Saar Vandekeere, Joanna Kalucka, et al.. (2017). Role of glutamine and interlinked asparagine metabolism in vessel formation. The EMBO Journal. 36(16). 2334–2352. 229 indexed citations

Maes, Brigitte, Bert Cruys, M. Janssen, et al.. (2017). Targeted next‐generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics. International Journal of Laboratory Hematology. 39(6). 604–612. 7 indexed citations

Cruys, Bert, Brian W. Wong, Anna Kuchnio, et al.. (2016). Glycolytic regulation of cell rearrangement in angiogenesis. Nature Communications. 7(1). 12240–12240. 132 indexed citations

Bentley, Katie, Martin L. Jones, & Bert Cruys. (2013). Predicting the future: Towards symbiotic computational and experimental angiogenesis research. Experimental Cell Research. 319(9). 1240–1246. 25 indexed citations

10.

Eelen, Guy, Bert Cruys, Jonathan Welti, Katrien De Bock, & Peter Carmeliet. (2013). Control of vessel sprouting by genetic and metabolic determinants. Trends in Endocrinology and Metabolism. 24(12). 589–596. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact